Pancreatic Cancer Research

ResearcherGarvan Institute of Medical ResearchActive in the last 2 years

Nam Quoc Nguyen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1270-5441; OpenAlex author ID A5030187765, A5103687063, A5110968413. Sources: OpenAlex.

Their work

Papers
16 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
44
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 3 papers · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 16

  1. Combined phosphorus-32 implantation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer: a propensity score-weighted landmark ana… Last author DOI 10.1016/j.gie.2025.04.054↗
  2. Histopathological Examination of Pancreatectomy Specimens From Patients With Locally Advanced Pancreatic Adenocarcinoma Following Endoscopic Ultrasound-Guided … Last author DOI 10.1111/pin.70131↗
  3. Emergent Role of Intra-Tumor Radioactive Implantation in Pancreatic Cancer. Last author DOI 10.3390/cancers18020302↗
  4. Impact of Different Modalities of Radiotherapy in Locally Advanced Pancreatic Cancer: A Review and Meta-Analysis. Last author DOI 10.1111/jgh.70036↗
  5. Outcomes of phosphorus-32 microparticle intratumoral implantation added to chemotherapy in patients with metastatic pancreatic adenocarcinoma. Last author DOI 10.1016/j.igie.2024.06.005↗
  6. Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRI… Co-author DOI 10.1016/j.esmoop.2021.100356↗
  7. Combined chemotherapy and endoscopic ultrasound-guided intratumoral 32P implantation for locally advanced pancreatic adenocarcinoma: a pilot study. Last author DOI 10.1055/a-1353-0941↗
  8. Editorial: Management of pancreatic cancer: Defining the targets for therapy. Co-author DOI 10.3389/fmed.2022.971067↗
  9. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk an… Co-author DOI 10.1186/s12885-021-08666-y↗
  10. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003143↗
  11. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  12. Whole genomes redefine the mutational landscape of pancreatic cancer. Co-author DOI 10.1038/nature14169↗
  13. Adjuvant chemotherapy in elderly patients with pancreatic cancer. Co-author DOI 10.1038/bjc.2013.722↗
  14. A case of pancreatic cancer in the setting of autoimmune pancreatitis with nondiagnostic serum markers. Co-author DOI 10.1155/2013/809023↗
  15. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Co-author DOI 10.1038/nature11547↗
  16. 18F-FDG-PET/CT in the assessment of pancreatic cancer: is the contrast or a better-designed trial needed? Co-author DOI 10.1111/j.1440-1746.2011.06625.x↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Amanda Huoy Wen Lim · 5 shared papers, 2024–2026 · strength 1.48
  2. Nimit Singhal · 4 shared papers, 2022–2026 · strength 0.83
  3. Pathipat Durongpongkasem · 1 shared paper, 2026 · strength 0.50
  4. Adnan M. Nagrial · 4 shared papers, 2014–2024 · strength 0.42
  5. Jeevinesh Naidu · 2 shared papers, 2022–2024 · strength 0.32
  6. Daniel Gerald Croagh · 2 shared papers, 2022–2024 · strength 0.31
  7. Harpreet Singh Wasan · 2 shared papers, 2022–2024 · strength 0.31
  8. Barry Allen · 1 shared paper, 2026 · strength 0.22
  9. Jaswinder Singh Samra · 3 shared papers, 2014–2021 · strength 0.21
  10. Lorraine A. Chantrill · 3 shared papers, 2014–2021 · strength 0.21
  11. Paul J. Ross · 1 shared paper, 2022 · strength 0.13
  12. Alain Hendlisz · 1 shared paper, 2022 · strength 0.13
  13. Marion Harris · 1 shared paper, 2022 · strength 0.13
  14. Mehrdad Nikfarjam · 1 shared paper, 2022 · strength 0.13
  15. Thankamma Ajithkumar · 1 shared paper, 2022 · strength 0.13
  16. Jeremy L. Humphris · 2 shared papers, 2014–2020 · strength 0.11
  17. James G. Kench · 2 shared papers, 2014–2020 · strength 0.11
  18. Angela S. Y. Chou · 2 shared papers, 2014–2020 · strength 0.11
  19. Amber L. Johns · 2 shared papers, 2014–2020 · strength 0.11
  20. Marina Pajic · 2 shared papers, 2014–2020 · strength 0.11
  21. Christopher James Scarlett · 2 shared papers, 2014–2020 · strength 0.11
  22. Venessa T. Chin · 2 shared papers, 2014–2020 · strength 0.11
  23. Emily K. Colvin · 2 shared papers, 2014–2020 · strength 0.11
  24. Anthony James Gill · 2 shared papers, 2014–2020 · strength 0.11
  25. David Kuang-Fu Chang · 2 shared papers, 2014–2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.